Q1 Earnings Estimate for Immunome Issued By Leerink Partnrs
Immunome, Inc. (NASDAQ:IMNM – Free Report) – Research analysts at Leerink Partnrs issued their Q1 2025 earnings estimates for shares of Immunome in a research report issued on Wednesday, February 5th. Leerink Partnrs analyst A. Berens anticipates that the company will post earnings of ($0.94) per share for the quarter. The consensus estimate for Immunome’s […]
![Q1 Earnings Estimate for Immunome Issued By Leerink Partnrs](https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/immunome-inc-logo-1200x675.png?v=20240509151305&w=240&h=240&zc=2)